Navigation Links
Study Reveals Effects of WBCs on Transplanted Kidney

A recent study in genetically engineered mice has revealed that the dreaded white blood cell chemistry known to damage kidneys used for transplants may also help prevent such damage//, according to scientists at Johns Hopkins.

Researchers have long known that when blood flow is cut off and then returned to transplanted kidneys or other organs, immune system cells called T lymphocytes produce toxic natural chemicals that contribute to ischemic reperfusion injury (IRI). Nature cannot distinguish between deliberate surgical wounds needed to remove and re-implant a donor kidney and other kinds of organ damage in which certain toxic chemicals are needed to clean up or remove bad tissue.

But in the new study published in the September issue of The Journal of Immunology, the Hopkins team reports that that T cells can also play a role in reducing cellular damage in IRI kidneys, according to Hamid Rabb, M.D., medical director of kidney and pancreas transplantation at The Johns Hopkins University School of Medicine.

IRI occurs in 30 percent to 40 percent of kidneys removed from dead donors, resulting in lower kidney survival rates, shortened kidney life and a cost increase of approximately $20,000 per patient from the initial hospital stay and treatment alone, according to Rabb. Scientists therefore are interested in identifying means of preventing or rapidly treating IRI, but one barrier to greater understanding has been the inability to detect the lymphocytes in the kidney during the first critical six hours after blood flow is returned.

In the Hopkins study, designed to try to find these cells and learn more about IRI, white blood cells were taken from mice that had undergone experimentally induced IRI. These cells were injected into mice engineered without a thymus gland, which produces T cells. A comparison group of genetically engineered mice got no injections.

After the researchers temporarily stopped blood flow to kidney
'"/>




Page: 1 2 3

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer

Post Your Comments:
(Date:12/1/2009)..., , RED BANK, N.J., Dec. 1 /PRNewswire/ ...rs know breastfeeding is ideal for their babies an...o decide what works best for them and their famili...inr.mediaseed.tv/IFC_37156/ ,, The survey of m...d that most mothers (83%) made their infant feedin...
(Date:12/1/2009)...iscovery could aid in development of simple screen...1 (HealthDay News) -- In a finding that could lead... U.S. researchers have identified immune system ma...ple at high risk for lung cancer. , The researc...mples from 137 people with non-small cell lung ca...
(Date:12/1/2009)...DC urges H1N1 vaccination because pandemic,s cours.... 1 (HealthDay News) -- A U.S. health official sai... be on the wane nationally, but many experts agree...r. , The flu is now widespread in 32 states -- ... Frieden, director of the U.S. Centers for Disease...
(Date:12/1/2009)... Ever thought you could qu...! Kevin Arthur Smith,s groundbreaking new system f...y, permanent. In just twenty eight days your cravi... , (PRWEB) December 1, 20...uring her eight-year addiction to nicotine, smokin...
(Date:12/1/2009)..., , ,, NEW YORK, Dec. 1 /P...and a global leader in the development and deliver...for the medical, scientific and academic markets, ...versal Search, our first-to-market cross-platform ...sychology lexicon, based on the American Psycholog...
Breaking Medicine News(10 mins):Health News:VIDEO from Medialink and HealthyWomen: Breast, Bottle or Both? 2Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3
...ill, arsenic also can prolong the lives of patient...aturday found. "This study shows that even...arlier in the course of treatment," said Dr. Bayar...erican Society of Oncology (ASCO) which brought to...
...JAMA, has identified novel genetic mutations linke... that these mutations are due to both independent ...as been released early to coincide with its presen...is the second most common cause of cancer death wo...
...sburgh Medical Center (UPMC) study presented at th...al Oncology (ASCO) in Chicago and published as Abs...ted for follicular lymphoma, a slow-growing type o...to the treatment and since only a short-course of ...
...nounced follow-up data from a Phase 2 clinical tri...ch was conducted by the Johns Hopkins Sidney Kimme...ith operable pancreatic cancer who received GVAX a... to be 26.8 months, a result which compares favora...
...end, even if it is all subtle, as in Canada appare...e hard to pin down is more dangerous to mental hea...dy of 180 Korean immigrants living in Canada. ...lead author Samuel Noh, professor of psychiatry at...
...g of SNM, the world's largest society for molecula...man researchers stated that early metabolic imagin...ely identifies patients responding to chemotherapy...the treatment of common solid tumors," said Ken He...
Other Medicine News:Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 2Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 3Health News:Lymphoma Patients Maybe Helped by Adding Radioimmunotherapy to Chemo 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 3Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 4Health News:Koreans in Canada Feel Put Down by Subtle Racism 2Health News:Esophageal Cancer Patients' Positive Responses to Chemotherapy Accurately Identified by PET 2
(Date:12/1/2009)...TER, N.J., Dec. 1 Tibotec Therapeu...s, L.P., announced today that it is launching a ne...g women and people of color living with HIV/AIDS. ...ducational events, media outreach and a new Web si...g learnings from the GRACE study, the largest clin...
(Date:12/1/2009)...D CITY, Calif., Dec. 1 Codexis, In...p and the signing of its second agreement this yea...rld,s largest generic drug manufacturer. The new ...products. Codexis announced an earlier agreement ...ent, Teva will use Codexis biocatalysis technology...
(Date:12/1/2009)...STON, Dec. 1 An expert f...XL ), a leading global biopharmaceutical services ...ve approaches to drug development in Asia at the P...ence, being held December 1-3, 2009 at the Interco... of the conference, which is focused on maximizing...
Breaking Medicine Technology:Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 3Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 4Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 5Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 6Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 7Codexis Expands Collaboration with Teva 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 3PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 4What scientists know about jewel beetle shimmer 9338 1What scientists know about jewel beetle shimmer 9338 2R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 1R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 2R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 3R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 4R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 5R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 6R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 7R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 8Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 1Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 2Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 3
...ogentus Pharmaceuticals,Inc. today announced that ...e full antiplatelet activity of its novel combinat...psule that combines clopidogrel (currently,markete...s Plavix(R)) with,a gastroprotectant (omeprazole) ...elet therapy., (Logo: http://www.newscom.com/cgi...
...fety Profile and Favorable Pharmacokinetics ... TRIANGLE PARK, N.C., Jan. 16 CeNeRx BioPharma,In...cializing innovative,treatments for diseases of th...essful completion of the Phase l clinical program ...nt of depression and anxiety. Tyrima is a,selectiv...
Other Medicine Technology:Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168 2CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM) 2CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM) 3
Lacrimal Cannula, Curved - Open End.
PremierEdge™ Implant Knives
Universal I/A handpiece - Titanium (Binkhorst Tip)
Universal I/A handpiece - Titanium (Curved Tip, Size: 16g Outer Cannula)
Medicine Products: